메뉴 건너뛰기




Volumn 7, Issue 4, 2012, Pages 367-370

Increasing the success rate for Alzheimer's disease drug discovery and development

Author keywords

Alzheimer's disease; clinical trials; drug development; methodological errors

Indexed keywords

ANTIBIOTIC AGENT; SULFANILAMIDE;

EID: 84859353052     PISSN: 17460441     EISSN: 1746045X     Source Type: Journal    
DOI: 10.1517/17460441.2012.672409     Document Type: Review
Times cited : (19)

References (18)
  • 1
    • 84884894746 scopus 로고    scopus 로고
    • Development, optimization and use of preclinical behavioral models to maximize the productivity of drug discovery for Alzheimer's disease
    • McArthur RA, Borsini F, editors. Academic Press; San Diego
    • Lindner MD, McArthur RA, Deadwyler SA, et al. Development, optimization and use of preclinical behavioral models to maximize the productivity of drug discovery for Alzheimer's disease. In: McArthur RA, Borsini F, editors. Animal and Translational Models for CNS Drug Discovery: Neurologic Disorders. Academic Press; San Diego: 2008. p. 93-157
    • (2008) Animal and Translational Models for CNS Drug Discovery: Neurologic Disorders , pp. 93-157
    • Lindner, M.D.1    McArthur, R.A.2    Deadwyler, S.A.3
  • 2
    • 78751613397 scopus 로고    scopus 로고
    • Report of the task force on designing clinical trials in early (preclinical) dementia
    • Aisen PS, Andrieu S, Sampaio C, et al. Report of the task force on designing clinical trials in early (preclinical) dementia. Neurology 2011;76:280-6
    • (2011) Neurology , vol.76 , pp. 280-286
    • Aisen, P.S.1    Andrieu, S.2    Sampaio, C.3
  • 3
    • 77649234756 scopus 로고    scopus 로고
    • How to improve R&D productivity: The pharmaceutical industry's grand challenge
    • Paul SM, Mytelka DS, Dunwiddle CT, et al. How to improve R&D productivity: the pharmaceutical industry's grand challenge. Nat Rev Drug Discov 2010;5:203-14
    • (2010) Nat Rev Drug Discov , vol.5 , pp. 203-214
    • Paul, S.M.1    Mytelka, D.S.2    Dunwiddle, C.T.3
  • 5
    • 3142512451 scopus 로고    scopus 로고
    • Back to the future: The 'old fashioned' way to new medications for neurodegenerations
    • Jul; Available From
    • Lansbury PT. Back to the future: the 'old fashioned' way to new medications for neurodegenerations. Nat Med. 2004 Jul;10 Suppl:S51-7. Available From: http://www.ncbi.nlm.nih.gov/ pubmed?term=Lansbury%20PT%20Back %20to%20the%20future
    • (2004) Nat Med , vol.10 , Issue.SUPPL.
    • Lansbury, P.T.1
  • 6
  • 7
    • 34447525109 scopus 로고    scopus 로고
    • Rating rater improvement: A method for estimating increased effect size and reduction of clinical trial costs [17]
    • DOI 10.1097/01.jcp.0000280315.81366.f8, PII 0000471420070800000029
    • Cogger KO. Rating rater improvement: a method for estimating increased effect size and reduction of clinical trial costs. J Clin Psychopharmacol 2007;27:418-20 This paper is practically informative about how power can be improved for clinical trials if steps are taken to insure the competence of raters. (Pubitemid 47075527)
    • (2007) Journal of Clinical Psychopharmacology , vol.27 , Issue.4 , pp. 418-420
    • Cogger, K.O.1
  • 9
    • 69949123520 scopus 로고    scopus 로고
    • Current Alzheimer's disease clinical trials: Methods and placebo outcomes
    • Schneider LS, Sano M. Current Alzheimer's disease clinical trials: methods and placebo outcomes. Alzheimer's Dement 2009;5:388-97
    • (2009) Alzheimer's Dement , vol.5 , pp. 388-397
    • Schneider, L.S.1    Sano, M.2
  • 10
    • 84873820438 scopus 로고    scopus 로고
    • Fire in the ashes: Can failed Alzheimer's drugs succeed with second chances?
    • In press
    • Becker RE, Greig NH. Fire in the ashes: can failed Alzheimer's drugs succeed with second chances? Alzheimer's Dement 2012; In press
    • (2012) Alzheimer's Dement
    • Becker, R.E.1    Greig, N.H.2
  • 11
    • 0004223940 scopus 로고
    • Cambridge University Press; Cambridge: This book is an authoritative reference on the problems of undetected errors interfering in complex systems and effective preemptive interventions
    • Reason J. Human Error. Cambridge University Press; Cambridge: 1990 This book is an authoritative reference on the problems of undetected errors interfering in complex systems and effective preemptive interventions.
    • (1990) Human Error
    • Reason, J.1
  • 12
    • 0033979004 scopus 로고    scopus 로고
    • Problems arising from the generalizing of treatment efficacy from clinical trials in Alzheimer's disease
    • Becker RE, Markwell S. Problems arising from the generalizing of treatment efficacy from clinical trials in Alzheimer's disease. Clin Drug Investig 2000;19:33-41
    • (2000) Clin Drug Investig , vol.19 , pp. 33-41
    • Becker, R.E.1    Markwell, S.2
  • 13
    • 48749125741 scopus 로고    scopus 로고
    • Alzheimer's disease drug development in 2008 and beyond: Problems and opportunities
    • Becker RE, Greig NH. Alzheimer's disease drug development in 2008 and beyond: problems and opportunities. Curr Alzheimer Res 2008;5:347-57
    • (2008) Curr Alzheimer Res , vol.5 , pp. 347-357
    • Becker, R.E.1    Greig, N.H.2
  • 14
    • 78650185148 scopus 로고    scopus 로고
    • Neuropsychiatric clinical trials: Lost in translation
    • DOI: 10.1126/scitranslmed.3000446
    • Becker RE, Greig NH. Neuropsychiatric clinical trials: lost in translation. Sci Transl Med 2:61-p. 61rv6; DOI: 10.1126/scitranslmed.3000446, 2010
    • (2010) Sci Transl Med , vol.2
    • Becker, R.E.1    Greig, N.H.2
  • 15
    • 34347403252 scopus 로고    scopus 로고
    • Drug development for CNS disorders: Strategies for balancing risk and reducing attrition
    • DOI 10.1038/nrd2094, PII NRD2094
    • Pangalos MN, Schechter LE, Hurko O. Drug development for CNS disorders: strategies for balancing risk and reducing attrition. Nat Rev Drug Discov 2007;6:521-32 (Pubitemid 47019441)
    • (2007) Nature Reviews Drug Discovery , vol.6 , Issue.7 , pp. 521-532
    • Pangalos, M.N.1    Schechter, L.E.2    Hurko, O.3
  • 16
    • 57649140590 scopus 로고    scopus 로고
    • Removing obstacles in neuroscience drug discovery: The future path for animal models
    • Markou A, Chiamulera C, Geyer MA, et al. Removing obstacles in neuroscience drug discovery: the future path for animal models. Neuropsychopharmacology 2009;34:74-89
    • (2009) Neuropsychopharmacology , vol.34 , pp. 74-89
    • Markou, A.1    Chiamulera, C.2    Geyer, M.A.3
  • 17
    • 84855454549 scopus 로고    scopus 로고
    • Farrrar, Straus and Giroux; New York
    • Kahneman D. Thinking, Fast and Slow. Farrrar, Straus and Giroux; New York: 2012. p. 209-12
    • (2012) Thinking, Fast and Slow , pp. 209-212
    • Kahneman, D.1
  • 18
    • 0010841241 scopus 로고
    • Cohen RS, Neurath M. editors. Reidel; Dordrecht
    • Neurath O. Philosophical Papers 1913-1946. In: Cohen RS, Neurath M. editors. Reidel; Dordrecht: 1983. p. 92
    • (1983) Philosophical Papers 1913-1946 , pp. 92
    • Neurath, O.1


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.